Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.20
31.10.23
€1.00
31.10.24
-15.47%
21.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Traumtanz 
31.10.23 50%
sell
Ayr Wellness Inc.

Start price
Target price
Perf. (%)
€1.12
30.10.23
-
30.10.24
145.11%
19.01.24

Risky Investment
Lokrim 
30.10.23 20%
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.06
29.10.23
€2.80
30.09.25
-
30.10.23

Could be very worthwhile Investment >20% year
BiotechBee 
29.10.23 60%
sell
CEL-SCI Corp.

Start price
Target price
Perf. (%)
€1.51
23.10.23
-
23.10.24
-23.18%
28.10.23

Could be worthwhile Investment >10% per year
Global_Player 
23.10.23 50%
buy
Oremex Silver

Start price
Target price
Perf. (%)
€0.005
18.10.23
€0.000
18.10.24
22.22%
24.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Traumtanz 
18.10.23 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€2.32
16.10.23
-
16.10.24
34.48%
11.12.23

Probably not worthwhile Investment
Lokrim 
16.10.23 20%
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.23
16.10.23
-
16.10.24
3.45%
28.10.23

Could be very worthwhile Investment >20% year
bundfuture 
16.10.23 50%
buy
Lyxor Ucits Etf Sicav (lux) - S&p 500 Vix Fut. Enh. Roll

Start price
Target price
Perf. (%)
€1.69
10.10.23
-
10.10.24
-24.00%
15.02.24

Dirk1 
10.10.23 50%
buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.21
09.10.23
-
09.10.24
1.99%
15.10.23

Could be worthwhile Investment >10% per year
Global_Player 
09.10.23 50%
sell
Microbot Medical Inc

Start price
Target price
Perf. (%)
€1.25
04.10.23
-
04.10.24
-8.80%
11.12.23

Probably not worthwhile Investment
Lokrim 
04.10.23 20%
buy
Leap Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.51
03.10.23
-
03.10.24
6.62%
04.10.23

me8 
03.10.23 0%
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.28
01.10.23
€2.00
30.09.25
14.84%
29.10.23

Could be very worthwhile Investment >20% year
BiotechBee 
01.10.23 50%
sell
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.64
30.09.23
€1.00
30.09.24
-9.76%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
nvestor 
30.09.23 50%
buy
Gulf Resources Inc.

Start price
Target price
Perf. (%)
€1.65
28.09.23
-
28.09.24
-7.88%
24.10.23

Wertexplorator 
28.09.23 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.12
27.09.23
-
27.09.24
-35.70%
30.09.23

Risky Investment
Vassago1 
27.09.23 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.47
26.09.23
-
26.09.24
-26.87%
15.10.23

Could be very worthwhile Investment >20% year
bundfuture 
26.09.23 50%
sell
Consolidated Uranium Inc.

Start price
Target price
Perf. (%)
€1.41
21.09.23
-
21.09.26
-14.23%
13.10.23

Could be very worthwhile Investment >20% year
robertinio 
21.09.23 100%
sell
Value Management+research

Start price
Target price
Perf. (%)
€1.62
19.09.23
€1.00
19.09.24
0.00%
30.09.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Normal challenges to pay loans and raise capital
kostojunior 
19.09.23 0%
sell
Palatin Technologies Inc.

Start price
Target price
Perf. (%)
€1.81
16.09.23
€1.00
16.09.24
-22.10%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
nvestor 
16.09.23 50%
sell
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€5.11
16.09.23
€2.00
16.09.24
-14.09%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
16.09.23 50%
buy
HelloFresh SE

Start price
Target price
Perf. (%)
€33.50
13.09.23
€35.00
13.09.24
-51.18%
17.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Traumtanz 
13.09.23 50%
sell
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€2.40
11.09.23
-
11.09.24
-22.50%
12.09.23

Probably not worthwhile Investment
Bankster 
11.09.23 50%
buy
HelloFresh SE

Start price
Target price
Perf. (%)
€29.30
06.09.23
€30.00
06.09.24
14.33%
13.09.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Traumtanz 
06.09.23 50%
buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€3.25
04.09.23
-
04.09.24
7.86%
11.12.23

Could be worthwhile Investment >10% per year
Lokrim 
04.09.23 20%
sell
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€1.72
04.09.23
€0.000
04.09.24
-19.03%
05.11.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
overvalued
Marianka 
04.09.23 40%